400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2019-02-20
新药研发企业
医药研发/制造
化学&生物药
Tichenor Ventures;
Tichenor Ventures;
Vida Ventures;
Vida Ventures;
Nextech Invest;
Eventide Asset Management;
RA Capital;
Driehaus Capital Management;
奥博资本;
curative Ventures;
EcoR1 Capital;
Topspin Fund;
The Column Group;
Foresite Capital;
BVF Partners
2016-09-15
新药研发企业
医药研发/制造
化学&生物药
Remeditex Ventures;
Remeditex Ventures;
Nextech Invest;
Nextech Invest;
Tichenor Ventures;
Topspin Fund;
The Column Group;
Foresite Capital
2015-03-23
生物制药商
医药研发/制造
化学&生物药
Topspin Fund;
Topspin Fund;
Prospect Venture Partners;
Prospect Venture Partners;
The Column Group;
Tichenor Ventures
2013-07-18
生物制药商
医药研发/制造
化学&生物药
Topspin Fund;
Topspin Fund;
Prospect Venture Partners;
Prospect Venture Partners;
Tichenor Ventures
2011-11-07
生物制药商
医药研发/制造
化学&生物药
Prospect Venture Partners;
Prospect Venture Partners;
The Column Group;
The Column Group;
Tichenor Ventures
2010-03-15
生物制药商
医药研发/制造
化学&生物药
Rho Ventures;
Rho Ventures;
Prospect Venture Partners;
Prospect Venture Partners;
Tichenor Ventures;
The Column Group
动脉网-最新2026-04-28
动脉网-最新2026-04-28
GlobeNewswire2026-04-28
GlobeNewswire2026-04-28
医药云端工作室2026-04-28
GlobeNewswire2026-04-28
GlobeNewswire2026-04-28
Businesswire2026-04-28
PRNewswire2026-04-28
PRNewswire2026-04-28